251 related articles for article (PubMed ID: 20433802)
21. Effect of preexisting neutralizing antibodies on the anti-tumor immune response induced by chimeric human papillomavirus virus-like particle vaccines.
Da Silva DM; Pastrana DV; Schiller JT; Kast WM
Virology; 2001 Nov; 290(2):350-60. PubMed ID: 11883199
[TBL] [Abstract][Full Text] [Related]
22. Induction of Hantaan virus-specific immune responses in C57BL/6 mice by immunization with a modified recombinant adenovirus containing the chimeric gene, GcS0.7.
Li K; Li PY; Wu XA; Zhang L; Liu ZY; Yu L; Zhang L; Cheng LF; Bai WT; Zhang FL; Xu ZK
Int J Mol Med; 2013 Sep; 32(3):709-16. PubMed ID: 23783439
[TBL] [Abstract][Full Text] [Related]
23. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
[TBL] [Abstract][Full Text] [Related]
24. Ebola virus-like particles produced in insect cells exhibit dendritic cell stimulating activity and induce neutralizing antibodies.
Ye L; Lin J; Sun Y; Bennouna S; Lo M; Wu Q; Bu Z; Pulendran B; Compans RW; Yang C
Virology; 2006 Aug; 351(2):260-70. PubMed ID: 16678231
[TBL] [Abstract][Full Text] [Related]
25. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
Vietheer PT; Boo I; Drummer HE; Netter HJ
Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
[TBL] [Abstract][Full Text] [Related]
26. Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains.
LoBue AD; Lindesmith L; Yount B; Harrington PR; Thompson JM; Johnston RE; Moe CL; Baric RS
Vaccine; 2006 Jun; 24(24):5220-34. PubMed ID: 16650512
[TBL] [Abstract][Full Text] [Related]
27. Immunization with Toscana virus N-Gc proteins protects mice against virus challenge.
Gori Savellini G; Di Genova G; Terrosi C; Di Bonito P; Giorgi C; Valentini M; Docquier JD; Cusi MG
Virology; 2008 Jun; 375(2):521-8. PubMed ID: 18355889
[TBL] [Abstract][Full Text] [Related]
28. [Comparative study on antibody levels of vaccination group and control group after 4 years of immunized with type B inactivated vaccine against hemorrhagic fever with renal syndrome].
Ruan Y; Liu W; Xu X; Weng SQ; Shao SK; Zhou WQ; Teng Z; Gu HX; Zhu ZY; Xu ZY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Sep; 15(3):274-6. PubMed ID: 11986705
[TBL] [Abstract][Full Text] [Related]
29. Incorporation of GM-CSF or CD40L Enhances the Immunogenicity of Hantaan Virus-Like Particles.
Cheng LF; Wang F; Zhang L; Yu L; Ye W; Liu ZY; Ying QK; Wu XA; Xu ZK; Zhang FL
Front Cell Infect Microbiol; 2016; 6():185. PubMed ID: 28066721
[TBL] [Abstract][Full Text] [Related]
30. Comparative analysis of immunoglobulin M (IgM) capture enzyme-linked immunosorbent assay using virus-like particles or virus-infected mouse brain antigens to detect IgM antibody in sera from patients with evident flaviviral infections.
Holmes DA; Purdy DE; Chao DY; Noga AJ; Chang GJ
J Clin Microbiol; 2005 Jul; 43(7):3227-36. PubMed ID: 16000440
[TBL] [Abstract][Full Text] [Related]
31. Kinetics and Immunodominance of Virus-Specific T Cell Responses During Hantaan Virus Infection.
Wang M; Wang J; Kang Z; Zhao Q; Wang X; Hui L
Viral Immunol; 2015 Jun; 28(5):265-71. PubMed ID: 25945718
[TBL] [Abstract][Full Text] [Related]
32. Immunological properties of a fusion protein containing nucleocapsid protein and glycoprotein Gn of Hantaan virus.
Luo W; Zhang F; Yan Y; Wu X; Liu Y; Bai W; Zhao Q; Wang H; Xu Z
Acta Virol; 2008; 52(4):243-9. PubMed ID: 19143481
[TBL] [Abstract][Full Text] [Related]
33. Truncated recombinant Dobrava hantavirus nucleocapsid proteins induce strong, long-lasting immune responses in mice.
Maes P; Keyaerts E; Bonnet V; Clement J; Avsic-Zupanc T; Robert A; Van Ranst M
Intervirology; 2006; 49(5):253-60. PubMed ID: 16714853
[TBL] [Abstract][Full Text] [Related]
34. A recombinant pseudotyped lentivirus expressing the envelope glycoprotein of hantaan virus induced protective immunity in mice.
Yu L; Bai W; Wu X; Zhang L; Zhang L; Li P; Wang F; Liu Z; Zhang F; Xu Z
Virol J; 2013 Oct; 10():301. PubMed ID: 24093752
[TBL] [Abstract][Full Text] [Related]
35. A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for haemorrhagic fever with renal syndrome delivered by intramuscular electroporation.
Hooper JW; Moon JE; Paolino KM; Newcomer R; McLain DE; Josleyn M; Hannaman D; Schmaljohn C
Clin Microbiol Infect; 2014 May; 20 Suppl 5():110-7. PubMed ID: 24447183
[TBL] [Abstract][Full Text] [Related]
36. Segments of puumala hantavirus nucleocapsid protein inserted into chimeric polyomavirus-derived virus-like particles induce a strong immune response in mice.
Gedvilaite A; Zvirbliene A; Staniulis J; Sasnauskas K; Krüger DH; Ulrich R
Viral Immunol; 2004; 17(1):51-68. PubMed ID: 15018662
[TBL] [Abstract][Full Text] [Related]
37. Fusion with extracellular domain of cytotoxic T-lymphocyte-associated-antigen 4 leads to enhancement of immunogenicity of Hantaan virus DNA vaccines in C57BL/6 mice.
Liu F; Liang M; Cao S; Liu Q; Zhang Q; Li C; Zhang S; Wang S; Li D
Virol J; 2011 Sep; 8():448. PubMed ID: 21943202
[TBL] [Abstract][Full Text] [Related]
38. A vaccinia virus-vectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul viruses but not Puumala virus.
Chu YK; Jennings GB; Schmaljohn CS
J Virol; 1995 Oct; 69(10):6417-23. PubMed ID: 7666542
[TBL] [Abstract][Full Text] [Related]
39. Construction and evaluation of DNA vaccine encoding Hantavirus glycoprotein N-terminal fused with lysosome-associated membrane protein.
Jiang DB; Sun YJ; Cheng LF; Zhang GF; Dong C; Jin BQ; Song CJ; Ma Y; Zhang FL; Yang K
Vaccine; 2015 Jun; 33(29):3367-76. PubMed ID: 26027907
[TBL] [Abstract][Full Text] [Related]
40. Structural Basis for a Neutralizing Antibody Response Elicited by a Recombinant Hantaan Virus Gn Immunogen.
Rissanen I; Krumm SA; Stass R; Whitaker A; Voss JE; Bruce EA; Rothenberger S; Kunz S; Burton DR; Huiskonen JT; Botten JW; Bowden TA; Doores KJ
mBio; 2021 Aug; 12(4):e0253120. PubMed ID: 34225492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
